trial · primary record
TRX103
Non Infectious Uveitis
| Phase | Phase 1 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 18 |
| Primary completion | 2028-12 |
| Primary endpoint | Incidence of Treatment emergent Adverse events and Serious Adverse events at week 52 |
| Registry ID | NCT07427628 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-02T15:44:39.550Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07427628
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.